C-2GLFAmelia Technologies
DNA damage quantification, aging therapeutics
research tools
Loading
Loading section...0-100 chain-logic scale · 15 dimensions · scored on public evidence
←All companiesC-2GLF
C-2GLFC-2GLFDNA damage quantification, aging therapeutics
0-100 chain-logic scale · 15 dimensions · scored on public evidence
Amelia Technologies DNA damage quantification, aging therapeutics
Amelia Technologies LLC is described as a biotechnology company founded in 2018 with laboratories and offices located at Rockville, MD. The company develops technologies that quantify DNA damage in cells and provide insight into therapeutics for aging disorders associated with DNA damage accumulation.
The published score reflects a curated read of public evidence across 16 dimensions. Each dimension below shows the rationale we used. Disagree with a reading? Tell us where we are wrong →
Higher up = higher Eternal Search score. Further right = closer to achieving real longevity outcomes (early mechanism → translational → near-term readout). Bubble size = capital deployed. Watch for MISMATCHES: big bubbles on the left are well-capitalized but far from goals; small bubbles on the right are doing more with less.
Amelia Technologies — Early mechanism · Lower middle. Derived deterministically from 6 extracted project(s). Most-advanced status: preclinical. Band: early_mechanism. Modifiers: +5 depth (2 programs at preclinical).…
Source: Deterministic